In summary, while restoring T cell function using an asparaginase-deficient STm comes at the cost of some tumour cell intrinsic control via c-Myc, there is still sustained tumour reduction and so T cell functionality alongside other tumour control mechanisms of STm elicit significant protection from autochthonous tumour growth. The gene discussed is ASPG; the disease is neoplasm.